# Competitive Gap Analysis Report

**Generated**: 2025-11-17T17:33:23.515897

## Executive Summary

**Owned Entity**: AbbVie
**Competitors Analyzed**: 1
**Content Gaps Identified**: 15

## Coverage Metrics

### AbbVie
- **Pages Crawled**: 2
- **Total Content Words**: 1,566
- **Avg Words per Page**: 783
- **Images**: 33
- **Links**: 101

### Pfizer
- **Pages Crawled**: 2
- **Total Content Words**: 1,591
- **Avg Words per Page**: 795
- **Images**: 39
- **Links**: 102

## Top Content Gaps

| # | Term | Competitor | Gap Priority | Your Coverage | Their Coverage |
|---|------|-----------|--------|---|---|
| 1 | **pfizer** | Pfizer | High | 0.00% | 25.01% |
| 2 | **vaccines** | Pfizer | High | 0.00% | 21.68% |
| 3 | **button** | Pfizer | High | 0.00% | 20.01% |
| 4 | **view** | Pfizer | High | 0.00% | 13.34% |
| 5 | **button previous** | Pfizer | High | 0.00% | 10.00% |
| 6 | **previous button** | Pfizer | High | 0.00% | 10.00% |
| 7 | **disease** | Pfizer | High | 0.00% | 10.00% |
| 8 | **previous** | Pfizer | High | 0.00% | 10.00% |
| 9 | **diseases** | Pfizer | Medium | 3.13% | 11.86% |
| 10 | **improve** | Pfizer | Medium | 0.00% | 8.34% |
| 11 | **enable** | Pfizer | Medium | 0.00% | 8.34% |
| 12 | **significantly** | Pfizer | Medium | 0.00% | 6.67% |
| 13 | **internal** | Pfizer | Medium | 0.00% | 6.67% |
| 14 | **internal medicine** | Pfizer | Medium | 0.00% | 6.67% |
| 15 | **treatment** | Pfizer | Medium | 0.00% | 6.67% |

## Recommendations

1. **High Priority Gaps**: Create content addressing these terms to match competitor coverage
2. **Medium Priority Gaps**: Enhance existing content with these topics
3. **Strategic Focus**: Prioritize gaps that align with business objectives
